EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy

Murtadha Al-Saady iD, Shanice Beerepoot iD, Bonnie C Plug, Marjolein Breur, Hristina Galabova, Petra J W Pouwels, Jaap-Jan Boelens, Caroline Lindemans, Peter M van Hasselt, Ulrich Matzner, Adeline Vanderver, Marianna Bugiani und 2 weitere

Annals of Clinical and Translational Neurology · 2023

DOI: 10.1002/acn3.51796 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2023. Verfasst von Murtadha Al-Saady und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child Neurology, Amsterdam Leukodystrophy Center, Emma Children's Hospital, Amsterdam University Medical Centers, and Amsterdam Neurosc…. Hauptthemen laut MEDLINE: Leukodystrophy, Metachromatic, Neurodegenerative Diseases, Hematopoietic Stem Cell Transplantation, Demyelinating Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Metachromatic leukodystrophy is a lysosomal storage disease caused by deficient arylsulfatase A. It is characterized by progressive demyelination and thus mainly affects the white matter. Hematopoietic stem cell transplantation may stabilize and improve white matter damage, yet some patients deteriorate despite successfully treated leukodystrophy. We hypothesized that post‐treatment decline in metachromatic leukodystrophy might be caused by gray matter pathology.

Methods

Three metachromatic leukodystrophy patients treated with hematopoietic stem cell transplantation with a progressive clinical course despite stable white matter pathology were clinically and radiologically analyzed. Longitudinal volumetric MRI was used to quantify atrophy. We also examined histopathology in three other patients deceased after treatment and compared them with six untreated patients.

Results

The three clinically progressive patients developed cognitive and motor deterioration after transplantation, despite stable mild white matter abnormalities on MRI. Volumetric MRI identified cerebral and thalamus atrophy in these patients, and cerebellar atrophy in two. Histopathology showed that in brain tissue of transplanted patients, arylsulfatase A expressing macrophages were clearly present in the white matter, but absent in the cortex. Arylsulfatase A expression within patient thalamic neurons was lower than in controls, the same was found in transplanted patients.

Interpretation

Neurological deterioration may occur after hematopoietic stem cell transplantation in metachromatic leukodystrophy despite successfully treated leukodystrophy. MRI shows gray matter atrophy, and histological data demonstrate absence of donor cells in gray matter structures. These findings point to a clinically relevant gray matter component of metachromatic leukodystrophy, which does not seem sufficiently affected by transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukodystrophy, MetachromaticNeurodegenerative DiseasesHematopoietic Stem Cell TransplantationDemyelinating DiseasesHumansCerebroside-SulfataseBrain

Substanzen

Cerebroside-Sulfatase

Autor:innen und Institutionen

  • Department of Child Neurology, Amsterdam Leukodystrophy Center, Emma Children's Hospital, Amsterdam University Medical Centers, and Amsterdam Neuroscience, Cellular & Molecular Mechanisms, Vrije Universiteit, Amsterdam,…
  • Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Nierkens and Lindemans Group, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Department of Pathology, Amsterdam Leukodystrophy Center, Amsterdam University Medical Centers, VU University and Neuroscience Campus Amsterdam, Amsterdam, the Netherlands.
  • Department of Radiology and Nuclear Medicine, Neuroscience Campus Amsterdam, Amsterdam University Medical Centers, VU university, Amsterdam, the Netherlands.
  • Stem Cell Transplantation and Cellular Therapies Program, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

ORCID-Profile: Murtadha Al-Saady, Shanice Beerepoot, Nicole I Wolf

Förderung

  • NCI NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Al-Saady, M., Beerepoot, S., Plug, B. C., Breur, M., Galabova, H., Pouwels, P. J. W., Boelens, J. J., Lindemans, C., van Hasselt, P. M., Matzner, U., Vanderver, A., Bugiani, M., van der Knaap, M. S., & Wolf, N. I. (2023). Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.51796

Vancouver

Al-Saady M, Beerepoot S, Plug BC, Breur M, Galabova H, Pouwels PJW, et al. Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy. Annals of Clinical and Translational Neurology. 2023. doi:10.1002/acn3.51796

BibTeX
@article{AlSaady2023,
  author = {Al-Saady, Murtadha and Beerepoot, Shanice and Plug, Bonnie C and Breur, Marjolein and Galabova, Hristina and Pouwels, Petra J W and Boelens, Jaap-Jan and Lindemans, Caroline and van Hasselt, Peter M and Matzner, Ulrich and Vanderver, Adeline and Bugiani, Marianna and van der Knaap, Marjo S and Wolf, Nicole I},
  title = {Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2023},
  doi = {10.1002/acn3.51796}
}
Kostenlos starten →